日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Small-molecule MMRi36 induces apoptosis in p53-mutant lymphomas by targeting MDM2/MDM4/XIAP for degradation.

小分子 MMRi36 通过靶向 MDM2/MDM4/XIAP 进行降解,诱导 p53 突变淋巴瘤细胞凋亡

Lama Rati, Wu Wenjie, Mavis Cory K, Ruiz Federico M, Querol-García Javier, Martin Diana, Chemler Sherry R, Chandra Dhyan, Goodrich David W, Hernandez-Ilizaliturri Francisco J, Muñoz Inés G, Wang Xinjiang

Population Pharmacokinetics and Pharmacodynamics of Carfilzomib in Combination with Rituximab, Ifosfamide, Carboplatin, and Etoposide in Adult Patients with Relapsed/Refractory Diffuse Large B Cell Lymphoma

卡非佐米联合利妥昔单抗、异环磷酰胺、卡铂和依托泊苷治疗复发/难治性弥漫性大B细胞淋巴瘤成人患者的群体药代动力学和药效学研究

Lin, Lan-Hsi; Ghasemi, Mohammad; Burke, Sarah M; Mavis, Cory K; Nichols, Jenna R; Torka, Pallawi; Mager, Donald E; Hernandez-Ilizaliturri, Francisco J; Goey, Andrew K L

Small molecule MMRi62 targets MDM4 for degradation and induces leukemic cell apoptosis regardless of p53 status

小分子MMRi62靶向MDM4使其降解,并诱导白血病细胞凋亡,且该作用不受p53状态的影响。

Lama, Rati; Xu, Chao; Galster, Samuel L; Querol-García, Javier; Portwood, Scott; Mavis, Cory K; Ruiz, Federico M; Martin, Diana; Wu, Jin; Giorgi, Marianna C; Bargonetti, Jill; Wang, Eunice S; Hernandez-Ilizaliturri, Francisco J; Koudelka, Gerald B; Chemler, Sherry R; Muñoz, Inés G; Wang, Xinjiang